Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Modeling the impact of obesity on the lifetime risk of chronic kidney disease in the United States using updated estimates of GFR progression from the CRIC study
  • Published Date:
    Oct 19 2018
  • Source:
    PLoS One. 13(10).
  • Language:
    English
Filetype[PDF-835.66 KB]


Details:
  • Alternative Title:
    PLoS One
  • Corporate Authors:
  • Description:
    Rationale & objective

    As the prevalence of obesity continues to rise in the United States, it is important to understand its impact on the lifetime risk of chronic kidney disease (CKD).

    Study design

    The CKD Health Policy Model was used to simulate the lifetime risk of CKD for those with and without obesity at baseline. Model structure was updated for glomerular filtration rate (GFR) decline to incorporate new longitudinal data from the Chronic Renal Insufficiency Cohort (CRIC) study.

    Setting and population

    The updated model was populated with a nationally representative cohort from National Health and Nutrition Examination Survey (NHANES).

    Outcomes

    Lifetime risk of CKD, highest stage and any stage.

    Model, perspective, & timeframe

    Simulation model following up individuals from current age through death or age 90 years.

    Results

    Lifetime risk of any CKD stage was 32.5% (95% CI 28.6%–36.3%) for persons with normal weight, 37.6% (95% CI 33.5%–41.7%) for persons who were overweight, and 41.0% (95% CI 36.7%–45.3%) for persons with obesity at baseline. The difference between persons with normal weight and persons with obesity at baseline was statistically significant (p<0.01). Lifetime risk of CKD stages 4 and 5 was higher for persons with obesity at baseline (Stage 4: 2.1%, 95% CI 0.9%–3.3%; stage 5: 0.6%, 95% CI 0.0%–1.1%), but the differences were not statistically significant (stage 4: p = 0.08; stage 5: p = 0.23).

    Limitations

    Due to limited data, our simulation model estimates are based on assumptions about the causal pathways from obesity to CKD, diabetes, and hypertension.

    Conclusions

    The results of this study indicate that obesity may have a large impact on the lifetime risk of CKD. This is important information for policymakers seeking to set priorities and targets for CKD prevention and treatment.

  • Pubmed ID:
    30339684
  • Pubmed Central ID:
    PMC6195263
  • Document Type:
  • Place as Subject:
  • Collection(s):
  • Main Document Checksum:
No Related Documents.
You May Also Like: